Selexis says $2m investment will speed up cell bank delivery time
Cell line developer Selexis has invested in laboratory equipment to reduce delivery times of its high expressing and stable research cell banks.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs